| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/1346-8138.13381 |
| P698 | PubMed publication ID | 27075942 |
| P50 | author | Erkan Alpsoy | Q57023526 |
| P2093 | author name string | Erkan Alpsoy | |
| P2860 | cites work | Gastrointestinal Behçet's disease: a review | Q28084556 |
| A double-blind trial of colchicine in Behçet's syndrome | Q28205622 | ||
| Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study | Q28207566 | ||
| 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides | Q28276589 | ||
| A double-blind trial of depot corticosteroids in Behçet's syndrome | Q28279953 | ||
| Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study | Q28943285 | ||
| Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci | Q28943327 | ||
| Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1 | Q28943506 | ||
| Gender-specific differences in Adamantiades-Behçet's disease manifestations: an analysis of the German registry and meta-analysis of data from the literature | Q30842385 | ||
| EULAR recommendations for the management of Behçet disease | Q33317927 | ||
| Relieving pain in minor aphthous stomatitis by a single session of non-thermal carbon dioxide laser irradiation | Q33328000 | ||
| Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis | Q33392365 | ||
| Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome | Q33555504 | ||
| Behçet's disease. | Q33755094 | ||
| Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease | Q34073780 | ||
| Interferon alfa-2a in the treatment of Behçet disease: a randomized placebo-controlled and double-blind study | Q34122642 | ||
| Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study | Q34134983 | ||
| Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease | Q34304205 | ||
| Behcet's Syndrome | Q34311953 | ||
| Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial | Q34459986 | ||
| Familial aggregation of Behçet's disease in Turkey | Q34509884 | ||
| Histopathologic features of erythema nodosum--like lesions in Behçet disease: a comparison with erythema nodosum focusing on the role of vasculitis | Q34511551 | ||
| The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center | Q34530754 | ||
| Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration | Q34600942 | ||
| HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies | Q34612338 | ||
| A controlled trial of azathioprine in Behçet's syndrome | Q34656107 | ||
| Influence of Sex on Patients with Behcet's Disease in Korea | Q34659007 | ||
| Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study | Q34980995 | ||
| Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study | Q35549915 | ||
| Skin prick test with self-saliva in patients with oral aphthoses: a diagnostic pathergy for Behcet's disease and recurrent aphthosis. | Q35585003 | ||
| New insights in the clinical understanding of Behçet's disease. | Q35648227 | ||
| A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease | Q35945533 | ||
| Mucocutaneous criteria for the diagnosis of Behçet's disease: an analysis of clinicopathologic data from multiple international centers | Q36703702 | ||
| Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations. | Q36778276 | ||
| Mucocutaneous lesions of Behcet's disease | Q36920297 | ||
| Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial | Q37296753 | ||
| Behçet's disease: an algorithmic approach to its treatment | Q37583633 | ||
| Letter: HL-A5 and Behçet's disease | Q37913071 | ||
| Improved clinical control of a challenging case of Behçet's disease with rituximab therapy | Q38168707 | ||
| Criteria for Behçet's disease with reflections on all disease criteria | Q38181670 | ||
| Silver nitrate cautery in aphthous stomatitis: a randomized controlled trial | Q38472426 | ||
| The efficacy and safety of 50 mg penicillin G potassium troches for recurrent aphthous ulcers | Q39386619 | ||
| Sustained relief of oral aphthous ulcer pain from topical diclofenac in hyaluronan: a randomized, double-blind clinical trial | Q39452931 | ||
| Treatment of recurrent aphthous ulcers with Aureomycin mouth rinse or Zendium dentifrice | Q39549981 | ||
| The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease | Q41514346 | ||
| Dermatologic manifestation of Behçet's disease. | Q41724555 | ||
| Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease | Q42189918 | ||
| Behcet's disease in Iran: analysis of 6500 cases. | Q42768402 | ||
| Pimecrolimus versus placebo in genital aphthous ulcers of Behcet's disease: a randomized double-blind controlled trial. | Q42939552 | ||
| Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study). | Q42939553 | ||
| Management of recurrent aphthous ulceration. A trial of chlorhexidine gluconate gel. | Q43612081 | ||
| Lack of efficacy of tocilizumab in mucocutaneous Behcet's syndrome: report of two cases | Q45794317 | ||
| Detection of RNA complementary to herpes-simplex virus in mononuclear cells from patients with Behçet's syndrome and recurrent oral ulcers | Q45806333 | ||
| Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa. | Q45937296 | ||
| Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet's disease | Q46211642 | ||
| Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001-4. | Q46687012 | ||
| Topical minocycline for managing symptoms of recurrent aphthous stomatitis | Q46756305 | ||
| Prevalence of Behçet's disease in Istanbul, Turkey. | Q47375572 | ||
| Effect of cyclosporine A on the hearing loss in Behçet's disease. | Q50543924 | ||
| Relationship between periodontal findings and Behçet's disease: a controlled study. | Q51020344 | ||
| Behçet disease: evolution of clinical manifestations. | Q51052844 | ||
| Demographic and clinical features of 521 Turkish patients with Behçet's disease. | Q51212096 | ||
| Inhibition of interleukin-1 by canakinumab as a successful mono-drug strategy for the treatment of refractory Behçet's disease: a case series. | Q51747604 | ||
| Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases. | Q51790725 | ||
| Upregulated IL-23 and IL-17 in Behçet patients with active uveitis. | Q51963776 | ||
| Clinical differentiation of oral ulceration in Behçet's disease. | Q52873531 | ||
| Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. | Q52952239 | ||
| The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. | Q53115269 | ||
| Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial. | Q53190954 | ||
| Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet's disease. | Q54442471 | ||
| Relationship between periodontal findings and the TNF-alpha Gene 1031T/C polymorphism in Turkish patients with Behçet's disease. | Q54541229 | ||
| CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease | Q56902650 | ||
| Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease | Q56968498 | ||
| Apremilast for Behçet’s Syndrome — A Phase 2, Placebo-Controlled Study | Q57096906 | ||
| Anakinra treatment in drug-resistant Behcet’s disease: a case series | Q58326155 | ||
| P433 | issue | 6 | |
| P921 | main subject | Behçet's disease | Q911427 |
| P304 | page(s) | 620-632 | |
| P577 | publication date | 2016-04-14 | |
| P1433 | published in | The Journal of Dermatology | Q18225322 |
| P1476 | title | Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions | |
| P478 | volume | 43 |
| Q36146582 | Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study. |
| Q64073524 | Association of HLA-B27 and Behcet's disease: a systematic review and meta-analysis |
| Q55432810 | Atypical Behçet disease with endocarditis, pyoderma gangrenosum–like ulcers and methicillin-resistant Staphylococcus aureus–positive skin abscesses. |
| Q55413268 | Autoimmune Diseases and Their Manifestations on Oral Cavity: Diagnosis and Clinical Management. |
| Q64263259 | Behçet's Disease: An Overview of Etiopathogenesis |
| Q41679943 | Behçet's disease: review with emphasis on dermatological aspects |
| Q47095460 | Breaking the Magic: Mouth and Genital Ulcers with Inflamed Cartilage Syndrome |
| Q55420686 | Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease. |
| Q90115206 | Cognitive Functioning and Silent Neurological Manifestations in Behçet's Disease with Ocular Involvement |
| Q99240127 | Cutaneous and Extracutaneous Manifestations of Behçet's Disease Linked to Its Disease Activity and Prognosis |
| Q64900172 | Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses. |
| Q37717740 | Erectile Dysfunction in Behcet's Disease |
| Q91993182 | Evaluation of the relationship between Behcet's disease and cardiovascular disorders through metabolic function and copeptin |
| Q58113388 | Evaluation of treatment adherence in patients with Behçet's disease: its relation to disease manifestations, patients' beliefs about medications, and quality of life |
| Q33605831 | Fibromyalgia in Behçet's disease: a narrative review |
| Q55140887 | Gene Expression Profiling in Behcet's Disease Indicates an Autoimmune Component in the Pathogenesis of the Disease and Opens New Avenues for Targeted Therapy. |
| Q39426072 | Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches |
| Q63352496 | Genome wide analysis for mouth ulcers identifies associations at immune regulatory loci |
| Q39059976 | Incidence and clinical outcomes of intestinal Behçet's disease in Korea, 2011-2014: a nationwide population-based study |
| Q42730515 | Knitting the Threads of Silk through Time: Behçet's Disease-Past, Present, and Future |
| Q38841182 | Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease |
| Q39154222 | Mean platelet volume as a marker for differentiating disease flare from infection in Behçet's disease |
| Q55101372 | MicroRNA Expression Profiling in Behçet's Disease. |
| Q42199614 | Neuro-Behçet disease mimicking brain tumor: A case report. |
| Q48373225 | Panax Notoginseng Saponin Controls IL-17 Expression in Helper T Cells |
| Q97524984 | Pathophysiology and therapy of systemic vasculitides |
| Q90303781 | Pediatric Behçet's disease - clinical aspects and current concepts |
| Q33710807 | Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases. |
| Q92482772 | Recurrent myocardial infarction due to coronary artery aneurysm in Behçet's syndrome: a case report |
| Q33760602 | Serum PLR and LMR in Behçet's disease: Can they show the disease activity? |
| Q89884802 | The Immediate Pain-Relieving Effects of Non-Thermal CO2 Laser Therapy on Genital Ulcers of Behcet's Disease: A Case Report |
| Q90012028 | The assessment of contributing factors to oral ulcer presence in Behçet's disease: Dietary and non-dietary factors |
| Q90319087 | Triggering agents and microbiome as environmental factors on Behçet's syndrome |
| Q53037870 | [Inflammatory diseases of oral mucous membranes]. |
Search more.